Xin Lang Cai Jing·2025-09-03 11:18Core Viewpoint - Junshi Bioscience has shown significant stock price appreciation in 2023, with a year-to-date increase of 73.14% and notable gains over various trading periods [2]. Group 1: Stock Performance - As of September 3, Junshi Bioscience's stock price reached 47.32 CNY per share, with a market capitalization of 48.583 billion CNY [1]. - The stock has increased by 9.08% over the last 5 trading days, 14.63% over the last 20 days, and 29.22% over the last 60 days [2]. Group 2: Financial Performance - For the first half of 2025, Junshi Bioscience reported revenue of 1.168 billion CNY, representing a year-on-year growth of 48.64% [2]. - The company recorded a net profit attributable to shareholders of -413 million CNY, which is a 36.01% increase compared to the previous period [2]. Group 3: Shareholder Information - As of June 30, 2025, the number of shareholders for Junshi Bioscience increased to 31,200, up by 5.88% from the previous period [2]. - The average number of circulating shares per shareholder decreased by 5.56% to 24,543 shares [2]. Group 4: Institutional Holdings - As of June 30, 2025, the top ten circulating shareholders include Huaxia SSE STAR 50 ETF, which holds 29.7167 million shares, a decrease of 536,700 shares from the previous period [3]. - E Fund SSE STAR 50 ETF increased its holdings to 22.2132 million shares, an increase of 630,000 shares [3].